Related Experiment Video
Updated: Apr 15, 2026
08:24
Introduction to the Ultrasound Targeted Microbubble Destruction Technique
Published on: June 12, 2011
16.2K
Academic pharmacy strikes Hawai'i. Part 2.
John M Pezzuto1, Carolyn S J Ma1
1Professor and Dean, Daniel K. Inouye College of Pharmacy, University of Hawai'i at Hilo, Hilo, HI (JMP).
Summary
The Daniel K. Inouye College of Pharmacy (DKICP) has graduated 341 pharmacists with a 96% licensing exam pass rate, significantly improving healthcare in Hawai'i and the Pacific. The college also launched a PhD program and secured substantial research funding.
Area of Science:
- Pharmaceutical Sciences
- Pharmacy Practice
- Health Professions Education
Background:
- The Daniel K. Inouye College of Pharmacy (DKICP) was established as Hawai'i's sole academic pharmacy program.
- The college's mission focuses on educating pharmacy practitioners and leaders to drive innovation in pharmaceutical sciences and practice.
Observation:
- DKICP has graduated 341 students with a 96% pass rate on national licensing board examinations.
- A Doctor of Philosophy (PhD) program has been initiated, featuring robust research in pharmacy practice and pharmaceutical sciences.
- The college has secured significant extramural funding from organizations like the National Institutes of Health and Centers for Medicare and Medicaid Services.
Findings:
- The college has demonstrably contributed to improving healthcare in Hawai'i and the Pacific Region.
- The economic impact of DKICP is estimated at over $50 million annually.
- Over 200 clinical affiliation agreements enhance pharmacist training and address workforce shortages.
Implications:
- DKICP plays a crucial role in addressing the shortage of pharmacists in Hawai'i.
- The college enhances the professional standing and practice standards of pharmacists within interprofessional healthcare teams.
- The program's success supports the broader goals of promoting health and well-being through advanced pharmaceutical education and research.
More Related Videos
Related Concept Videos
01:26Pharmaceutical Poisoning: Potential Scenarios
102
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
102
01:22Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
250
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
250
01:17Healthcare Agencies II
1.1K
There are various healthcare agencies in the United States—some of which are managed by religious institutions and others by different government branches.
Parish nursing is a growing specialty nursing profession that focuses on holistic healthcare, health promotion, and illness prevention. It blends professional nursing practice with a health ministry, focusing on health and healing within the context of a Christian community. Parish nurses serve as health educators, referral sources,...
Parish nursing is a growing specialty nursing profession that focuses on holistic healthcare, health promotion, and illness prevention. It blends professional nursing practice with a health ministry, focusing on health and healing within the context of a Christian community. Parish nurses serve as health educators, referral sources,...
1.1K
01:19Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
228
Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...
228
01:28Drug Products: Biologics, Biosimilars and Interchangeables
360
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
360
01:27Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
224
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
224